Abstract
It has been reported in heart transplantation that heart transplant patients who develop HLA class II (DQ) donor-specific antibodies have a higher risk to develop TCAD. Subsequently, there may be antibody production against DQ antigens after transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have